Large-scale testing (Phase 3)Study completedNCT03123939What this trial is testingPhase III B in Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 69
Not applicableLooking for participantsNCT07071051What this trial is testingExploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot StudyWho this might be right forChildhood Acute Lymphoblastic LeukemiaChildhood Lymphoblastic Lymphoma Mayo Clinic 15
Early research (Phase 1)Ended earlyNCT00313053What this trial is testingStudy of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL) Clare Twist 4
Early research (Phase 1)Active Not RecruitingNCT01860937What this trial is testingT-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic LeukemiaWho this might be right forRelapsed B-Cell Acute Lymphoblastic Leukemia Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT06395103What this trial is testingSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Who this might be right forB-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt Lymphoma+2 more Merck Sharp & Dohme LLC 90
Testing effectiveness (Phase 2)Study completedNCT00002621What this trial is testingInterferon Alfa in Treating Children With HIV-Related CancerWho this might be right forLeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific Children's Oncology Group 8
Not applicableStudy completedNCT03471416What this trial is testingNutritional Status in Children With ALL in GuatemalaWho this might be right forAcute Lymphoblastic Leukemia Columbia University 109
Testing effectiveness (Phase 2)Study completedNCT00315705What this trial is testingClofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.Who this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaRelapsed Leukemia Genzyme, a Sanofi Company 50
Early research (Phase 1)Study completedNCT00217412What this trial is testingVorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaWho this might be right forChildhood Acute Promyelocytic Leukemia (M3)Childhood Atypical Teratoid/Rhabdoid TumorChildhood Burkitt Lymphoma+16 more National Cancer Institute (NCI) 60
Very early researchStudy completedNCT00013533What this trial is testingPilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesWho this might be right forHodgkin LymphomaLymphocytic LeukemiaMixed Cell Leukemia+6 more National Cancer Institute (NCI) 30
Very early researchNot Yet RecruitingNCT07406178What this trial is testingJY509 Universal NK Cell Injection for the Treatment of Relapsed/Refractory Pediatric B-ALLWho this might be right forRelapsed/Refractory Pediatric B-ALL Institute of Hematology & Blood Diseases Hospital, China 18
Early research (Phase 1)Study completedNCT04888468What this trial is testingPhase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and AdolescentsWho this might be right forAcute Lymphoblastic LeukemiaRelapsed Pediatric ALLRefractory Acute Lymphoblastic Leukemia Chongqing Precision Biotech Co., Ltd 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06703216What this trial is testingPre-emptive Anakinra for Cytokine Event ReductionWho this might be right forB-Acute Lymphoblastic LeukemiaCAR-T Cell TherapyCytokine Release Syndrome+2 more Ann & Robert H Lurie Children's Hospital of Chicago 24
Testing effectiveness (Phase 2)UnknownNCT03022747What this trial is testingOptimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using AllopurinolWho this might be right forLymphoblastic Leukemia, Acute, Childhood Vastra Gotaland Region 60
Testing effectiveness (Phase 2)Study completedNCT00365768What this trial is testingGlutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid TumorsWho this might be right forKidney CancerLeukemiaLymphoma+3 more Columbia University 56
Testing effectiveness (Phase 2)Looking for participantsNCT03934372What this trial is testingSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid TumorsWho this might be right forAcute Myeloid LeukemiaAccelerated Phase Chronic Myeloid LeukemiaBlast Phase Chronic Myeloid Leukemia+6 more Incyte Biosciences International Sàrl 70
Testing effectiveness (Phase 2)Study completedNCT03373071What this trial is testingAnti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHLWho this might be right forCD19-ALLCD19-LNH Bambino Gesù Hospital and Research Institute 29
Testing effectiveness (Phase 2)WithdrawnNCT05320380What this trial is testingThe Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatWho this might be right forRecurrent Acute Myeloid LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute Leukemia+5 more Children's Oncology Group
Early research (Phase 1)Study completedNCT01077544What this trial is testingA Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)Who this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 15
Not applicableActive Not RecruitingNCT06476665What this trial is testingLearn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.Who this might be right forAcute Lymphocytic Leukemia Pfizer 7